We are live on ! Find out more
AIM

AIM ImmunoTech
AIM

32 hedge funds and large institutions have $5.88M invested in AIM ImmunoTech in 2020 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 5

45% more funds holding

Funds holding: 22 → 32 (+10)

27% more capital invested

Capital invested by funds: $4.64M → $5.88M (+$1.24M)

Holders
32
Holders Change
+10
Holders Change %
+45.45%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
10
Reduced
1
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$823K
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$292K
3
GCP
GSA Capital Partners
United Kingdom
+$239K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$167K
5
BCM
Bayesian Capital Management
New York
+$105K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$92.4K
2
SAMH
Shanda Asset Management Holdings
British Virgin Islands
-$72K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$63K
4
CS
Credit Suisse
Switzerland
-$44K
5
MFG
Magnus Financial Group
New York
-$35K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$1.73M +$823K +3,294 +69%
BlackRock
2
BlackRock
New York
$1.08M +$67.7K +271 +6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$870K +$90.4K +362 +10%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$476K +$167K +668 +43%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$251K +$292K +1,169 New
GCP
6
GSA Capital Partners
United Kingdom
$206K +$239K +958 New
HighTower Advisors
7
HighTower Advisors
Illinois
$151K +$100K +401 +134%
Northern Trust
8
Northern Trust
Illinois
$140K +$19.2K +77 +13%
SWM
9
SeaCrest Wealth Management
New York
$109K +$9.99K +40 +9%
Wells Fargo
10
Wells Fargo
California
$92K +$14.2K +57 +15%
BCM
11
Bayesian Capital Management
New York
$91K +$105K +422 New
Verition Fund Management
12
Verition Fund Management
Connecticut
$86K +$99.9K +400 New
Cambridge Investment Research Advisors
13
Cambridge Investment Research Advisors
Iowa
$73K +$85.4K +342 New
VF
14
Virtu Financial
New York
$64K -$92.4K -370 -56%
Bank of New York Mellon
15
Bank of New York Mellon
New York
$60K +$69.9K +280 New
AWA
16
Arkadios Wealth Advisors
Georgia
$45.4K +$50K +200 New
Charles Schwab
17
Charles Schwab
California
$44K – – –
LPL Financial
18
LPL Financial
California
$44K +$51.2K +205 New
Rockefeller Capital Management
19
Rockefeller Capital Management
New York
$43K +$50K +200 New
JP Morgan Chase
20
JP Morgan Chase
New York
$37K +$43.5K +174 New
Bank of America
21
Bank of America
North Carolina
$36K +$1.5K +6 +4%
Citadel Advisors
22
Citadel Advisors
Florida
$36K +$41.5K +166 New
TCM
23
Traynor Capital Management
Pennsylvania
$31K +$7.49K +30 +25%
WS
24
Wedbush Securities
California
$29K +$33.2K +133 New
XM
25
XTX Markets
New York
$26K +$29.7K +119 New
1
2

AIM Hedge Fund Activity: Q3 2020 in Review

32 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in AIM ImmunoTech (AIM) for Q3 2020, worth a combined $5.88M — up 27% from $4.64M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AIM positions and 5 closed out — a net gain of 10 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $823K. The largest seller was Virtu Financial, cutting an estimated $92.4K.

  • 32 institutional investors held AIM ImmunoTech (AIM) as of Q3 2020, up from 22 in Q2 2020.
  • Funds reported $5.88M of AIM ImmunoTech stock for Q3 2020, up 27% quarter-over-quarter.
  • 15 funds opened new AIM ImmunoTech positions in Q3 2020 and 5 closed out, a net change of +10 holders.
  • The largest AIM ImmunoTech buyer in Q3 2020 was Morgan Stanley, an estimated $823K added.
  • The largest AIM ImmunoTech seller in Q3 2020 was Virtu Financial, an estimated $92.4K sold.

Based on aggregated 13F filings for Q3 2020.